Account wins from the 11/28/06 news brief

Share this article:
Wishbone-ITP won the consumer and professional advertising business for Auxilium’s prescription testosterone replacement therapy, Testim. Pacific Communications has been named agency of record for Juvederm, Allergan’s dermal filler family of products approved in June for treating facial wrinkles and folds. Pacific, which is owned by Allergan, also handles Botox Cosmetic and other physician-dispensed skincare treatments in Allergan’s facial aesthetics portfolio. Roche switched professional agencies for its top-selling hepatitis C therapy Pegasys to Omnicom’s Harrison & Star from echo Torre Lazur, part of Interpublic Group’s McCann Healthcare Worldwide. The move followed a three-way pitch among Harrison & Star, GSW and one other agency. Pegasys is the world’s best-selling treatment for chronic hepatitis C. The drug brought in $1.13 billion in revenue last year, a 17% increase over 2004.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.